Abstract: A slide board system that includes a slide board, a first bumper selectively connected to the slide board and positioned at a first end of the slide board, the first bumper comprising one or more sensors, a second bumper selectively connected to the slide board and positioned at a second end of the slide board opposite the first end, a processing system including a processor and a memory, the memory storing instructions include receiving a data from the one or more sensors, calculating a plurality of metrics from the data, and outputting the metrics to a display.

Abstract: A method for providing a steady state plasma concentration of about 20-400 ng/ml of isoflavonoid compounds comprising the steps of a first rectal administration of the compound in a lipophilic suppository base followed by further rectal administrations no earlier than 4, 8 or 16 hours after the previous rectal administration.

Abstract: The present invention provides methods of treating inflammation associated with infection, and methods of preventing or reducing the severity of sepsis caused by inflammation associated with infection, in an individual comprising, consisting essentially of or consisting of the steps of administering a therapeutically effective amount of idronoxil, or derivative, pharmaceutically acceptable salt, ester, amide, polymorph and/or prodrug thereof to the individual, wherein the individual is diagnosed with, or suspected of having, early stage organ damage caused by inflammation associated with infection.

Abstract: The invention relates to a method for inducing an abscopal response to radiotherapy in an individual.

Abstract: A method for inducing abscopal, complete or partial response to radiotherapy comprising administering isoflavone compounds and irradiating with a cytotoxic dose of ionising radiation so that fewer than all of the plurality of tumours are irradiated.

Abstract: The invention relates to cancer therapy, especially to cytotoxic agents and chemo-sensitizing and radio-sensitising agents, particularly isoflavonoids, and to improving the bioavailability of same.

Abstract: The present invention provides methods of treating inflammation associated with infection, and methods of preventing or reducing the severity of sepsis caused by inflammation associated with infection, in an individual comprising, consisting essentially of or consisting of the steps of administering a therapeutically effective amount of idronoxil, or derivative, pharmaceutically acceptable salt, ester, amide, polymorph and/or prodrug thereof to the individual, wherein the individual is diagnosed with, or suspected of having, early stage organ damage caused by inflammation associated with infection.

Abstract: A method for improving a response in an individual to immuno-oncology therapy for cancer.

Abstract: The invention relates to methods for treating or minimising nervous system excitotoxicity, or a condition associated with excitotoxicity, through inhibition of calcium release and/or calcium uptake from a cell, in an individual utilising a compound according to general formula (1).

Abstract: A method for providing isoflavonoid compounds to the central nervous system comprising the step of rectally administering the compound to an individual in need thereof. This method is useful in the treatment of brain cancers, including glioblastoma multiforme.

Abstract: A method for inducing abscopal, complete or partial response to radiotherapy comprising administering isoflavone compounds and irradiating with a cytotoxic dose of ionising radiation so that fewer than all of the plurality of tumours are irradiated.

Abstract: Benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence. The cancer can be one or more of pancreatic cancer, colorectal cancer, melanoma, prostate cancer, brain cancer (including paediatric and adult), ovarian cancer, breast cancer, lung cancer, liver cancer, uterine cancer, neuroblastoma, mesothelioma, malignant ascites or peritoneal cancer.

Abstract: The invention relates to cancer therapy, especially to cytotoxic agents and chemo-sensitizing and radio-sensitising agents, particularly isoflavonoids, and to improving the bioavailability of same.

Abstract: A method for providing a steady state plasma concentration of about 20-400 ng/ml of isoflavonoid compounds comprising the steps of a first rectal administration of the compound in a lipophilic suppository base followed by further rectal administrations no earlier than 4, 8 or 16 hours after the previous rectal administration.

Abstract: A method for treating or preventing cancer including administering to a person in need thereof a first composition including a platin, a taxane, or combination of same and a second composition including an isoflavonoid.

Abstract: Benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence. The cancer can be one or more of pancreatic cancer, colorectal cancer, melanoma, prostate cancer, brain cancer (including paediatric and adult), ovarian cancer, breast cancer, lung cancer, liver cancer, uterine cancer, neuroblastoma, mesothelioma, malignant ascites or peritoneal cancer.

Abstract: A cistern comprises an upper water tank as a first chamber, and a lower water tank as a second chamber connected by an opening. At the top of the upper tank a mains water inlet allows mains water into the tank through an inlet valve, which is under the control of an upper float. An auxiliary water inlet allows water from an auxiliary supply, such as condensate from an air-conditioning unit, into the tank. At the bottom of lower tank is an water outlet, which allows flushing water from the lower tank 104 to flush an appliance (not shown) under the control of an outlet valve. The outlet valve is under the control of an actuator, which is configured to move up and down, and is also under the control of a lower float.

Abstract: The present invention relates broadly to anti-cancer agents. In particular, the present invention relates to selected benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence.

Abstract: A composition for treatment of a dermal injury including a micro-particulate glucan (MPG); and a preservative in the form of an alcohol; wherein the MPG is provided in an amount effective for enabling the composition to induce wound healing or wound repair.

Abstract: The present invention relates broadly to anti-cancer agents. In particular, the present invention relates to selected benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence.